Published in Gene Therapy Weekly, February 20th, 1995
Gesine Kogler and colleagues, Heinrich-Heine University, Dusseldorf, Germany, conducted a study of the Ceprate LC34 Biotin-Avidin affinity system (Cell Pro, Brussels, Belgium) to determine its value in enriching CD34+ cells from fresh unseparated and from thawed unseparated cord blood ("Evaluation of the Ceprate LC34 Affinity System for the Enrichment of CD34+ Hematopoietic Stem Cells from Cord Blood," Blood Cells, 1994;20:371-375).
Kogler et al. noted that cord blood is known...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.